BASAL CELL CARCINOMA WITH LYMPH NODE METASTASIS A CASE REPORT AND REVIEW OF LITERATURE
Author(s) -
O. Elatiqi,
MD. Elamrani,
Y. Benchamkha
Publication year - 2022
Publication title -
international journal of advanced research
Language(s) - English
Resource type - Journals
ISSN - 2320-5407
DOI - 10.21474/ijar01/14099
Subject(s) - basal cell carcinoma , medicine , merkel cell carcinoma , vismodegib , radiation therapy , lymph node , basal cell , skin cancer , lymphatic system , chemotherapy , metastasis , cancer , carcinoma , lymph , oncology , radiology , pathology
Basal cell carcinoma (BCC) is the most common skin cancer. Metastatic BCC is rare (0,0028% to 0,5%), with a very poor prognosis, survival rates of 3 years, in cases of locoregional lymphatic metastases,is estimated at 8 months. For this form of basal cell carcinoma,treatment is based on surgery and radiotherapy, chemotherapy bye Platinum-based or the inhibitors of the Hedgehog vismodegibcan be used for non-operative patients. We report a case of a 41 years old male man who suffered from BCC on his right cheek with lymph node metastases.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom